Medicare Enrolled
Dr. John Lehman, MD
Cardiovascular Disease · Belleville, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lehman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lehman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lehman
Dr. John Lehman is a cardiovascular disease specialist in Belleville, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lehman performed 2,289 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lehman received a total of $7,070 from 32 pharmaceutical and/or device companies across 442 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lehman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 2,289 Medicare services
$7,070 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,289
Medicare services
Bottom 48% in IL for cardiovascular disease
Not available
Unique patients (not deduplicated)
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
606 | $6 | $38 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
524 | $92 | $229 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
283 | $10 | $62 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
197 | $62 | $308 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
169 | $63 | $151 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
144 | $96 | $350 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
67 | $105 | $281 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
55 | $16 | $80 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
55 | $11 | $62 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
51 | $142 | $751 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
32 | $94 | $500 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
28 | $139 | $374 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
17 | $19 | $81 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
16 | $47 | $470 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
16 | $6 | $23 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
16 | $2 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $132 | $351 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
9.3% high complexity
10.6% medium
80.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,070
Total received (2018-2024)
Avg $1,010/year across 7 years
Top 30% in IL for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
442
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,874
2023
$1,100
2022
$1,075
2021
$1,165
2020
$471
2019
$559
2018
$826
Payments by company (2024)
Amgen Inc.
$236
Novartis Pharmaceuticals Corporation
$222
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$210
PFIZER INC.
$183
Kiniksa Pharmaceuticals International, plc
$163
Boston Scientific Corporation
$158
Merck Sharp & Dohme LLC
$104
Lexicon Pharmaceuticals, Inc.
$94
iRhythm Technologies, Inc.
$82
SANOFI-AVENTIS U.S. LLC
$78
Novo Nordisk Inc
$76
Janssen Pharmaceuticals, Inc
$73
AstraZeneca Pharmaceuticals LP
$51
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
Vital Connect, Inc
$23
E.R. Squibb & Sons, L.L.C.
$20
Esperion Therapeutics, Inc.
$19
SCPHARMACEUTICALS INC.
$18
Medtronic, Inc.
$18
CVRx, Inc.
$9
Top 3 companies account for 35.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,357
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$861
Novartis Pharmaceuticals Corporation
$751
Janssen Pharmaceuticals, Inc
$571
PFIZER INC.
$477
Merck Sharp & Dohme LLC
$383
Boehringer Ingelheim Pharmaceuticals, Inc.
$373
Boston Scientific Corporation
$257
Esperion Therapeutics, Inc.
$223
AstraZeneca Pharmaceuticals LP
$214
Kiniksa Pharmaceuticals International, plc
$163
E.R. Squibb & Sons, L.L.C.
$149
SANOFI-AVENTIS U.S. LLC
$142
Lexicon Pharmaceuticals, Inc.
$133
Merck Sharp & Dohme Corporation
$126
Kowa Pharmaceuticals America, Inc.
$121
Bayer HealthCare Pharmaceuticals Inc.
$118
Gilead Sciences, Inc.
$108
iRhythm Technologies, Inc.
$107
Novo Nordisk Inc
$92
Amarin Pharma Inc.
$65
Kiniksa Pharmaceuticals, Ltd.
$48
Astellas Pharma US Inc
$42
SCPHARMACEUTICALS INC.
$35
Bardy Diagnostics, Inc.
$32
Vital Connect, Inc
$23
Bayer Healthcare Pharmaceuticals Inc.
$21
CMP Pharma, Inc.
$19
Medtronic, Inc.
$18
Otsuka America Pharmaceutical, Inc.
$16
Relypsa, Inc.
$16
CVRx, Inc.
$9
Top 3 companies account for 42.0% of all-time payments
Associated products mentioned in payments ›
Arcalyst · BRILINTA · Barostim Neo System · CAMZYOS · CHANTIX · Carnation Ambulatory Monitor · CaroSpir · Corlanor · ELIQUIS · ENTRESTO · FARXIGA · FUROSCIX · Inpefa · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LINQ II · LifeVest · Livalo · MULTAQ · NEXLETOL · Ozempic · PRADAXA · PRALUENT · Repatha · Rybelsus · SAMSCA · STEGLATRO · VERQUVO · VITALPATCH RTM · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · WATCHMAN Access System · XARELTO · ZIO Patch · ZIO XT Patch · Zio monitor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
195
County median income
$70,178
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lehman is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lehman experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Lehman performed 606 ekg interpretation and report services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lehman receive payments from pharmaceutical companies?
Yes. Dr. Lehman received a total of $7,070 from 32 companies across 442 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lehman's costs compare to other cardiologists in Belleville?
Dr. Lehman's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lehman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Belleville
Browse cardiologists in Belleville ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in IL
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in IL
Which IL cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology